Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria

发表于 2026-9-20 15:46:55

期刊：JAMA Dermatology

文献作者：Michael D. Tharp; Jonathan A. Bernstein; Abhishek Kavati; Benjamin Ortiz; Karen MacDonald; Kris Denhaerynck; Ivo Abraham; Christopher S. Lee

出版日期：2019-1-1

DOI号：10.1001/jamadermatol.2018.3447

下载链接：https://jamanetwork.com/journals ... fullarticle/2713952

文献链接：https://doi.org/10.1001/jamadermatol.2018.3447

当前文献来源于 American Medical Association (AMA)。

备注信息：

发表于 2026-9-20 15:46:56

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[JAMA] Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[JAMA] Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria 一键复制